NEW RESEARCH—Associated lifestyle factors and comorbidities of difficult-to-treat rheumatoid arthritis: a systematic review and meta-analysis bit.ly/4tSOebX
Plus linked Comment bit.ly/4cFTGIr
#Medsky #Rheumsky
(A) Soluble GLP-1 concentrations in plasma and synovial fluid in patients with rheumatoid arthritis (n=22), spondyloarthritis (n=22), and in plasma in healthy controls (n=29). (B) Soluble DPP-4 activity in plasma and synovial fluid in patients with rheumatoid arthritis (n=12), spondyloarthritis (n=18), and in plasma in healthy controls (n=7).
NEW—Detection of GLP-1 and DPP-4 in synovial fluid: implications for therapeutical strategies in arthritis
bit.ly/4my0EUf #MedSky #RheumSky
Mechanism of glucocorticoid actions
NEW REVIEW—Glucocorticoid treatment in patients with inflammatory rheumatic diseases: current practice and open questions bit.ly/3PP9xwD
NEW podcast episode 🎧
As part of our theme issue on patient and public involvement in rheumatology, Aisling O'Brien talks to Jon Lampa about patient-reported outcomes from the NORD-STAR trial
Listen on
Apple bit.ly/4rYkOYD
Spotify bit.ly/4cdG4oB
Full Article bit.ly/411D48I
#Medsky #Rheumsky
💥 KABOOM!
Our #LupusGPT work is now published in @thelancetrheum.bsky.social‼️
🏆 A big moment for LupusGPT, but also for what can happen when patient voice is built in from the start, not added at the end.
Free. Multilingual. Valid information on lupus
doi.org/10.1016/S266...
Correlation between clinical variables and disease activity
NEW RESEARCH—Development and validation of clinical criteria for the definition of disease activity in adult-onset Still's disease: a cohort study bit.ly/4rZwyKH
Plus, linked Comment bit.ly/4dgPYHf #Medsky #Rheumsky
Early treatment for #RheumatoidArthritis leads to significant improvements in pain, fatigue, and quality of life – regardless of whether patients receive biologic drugs or conventional therapy. New KI study published in @thelancetrheum.bsky.social 🧪 #Rheumatology news.ki.se/early-initia...
Our April 2026 issue is live!
This themed issue on patient and public involvement in rheumatology includes priority setting partnerships, study co-design, and co-production of self-management tools and care pathways, plus much more! thelancet.com/journals/lan...
Cover by @emma-cheng.bsky.social
NEW RESEARCH—A treat-to-target strategy versus symptom-driven management of gout in the Netherlands (GO TEST Overture): a multicentre, open-label, pragmatic, superiority, randomised controlled trial
bit.ly/4sYp5MO #Medsky #Rheumsky
NEW Correspondence—Effects of abatacept for those at high risk of rheumatoid arthritis
@koraytascilar.bsky.social and colleagues report the long-term outcomes of individuals at risk of rheumatoid arthritis treated with abatacept or placebo in the ARIAA trial bit.ly/4lKYGQ3 #Medsky #Rheumsky
NEW RESEARCH—Ixekizumab in children with active psoriatic and enthesitis-related juvenile idiopathic arthritis: a multicentre, open-label, Bayesian trial including a randomised reference group to adalimumab bit.ly/4sDik2E
Plus, linked Comment bit.ly/3P92Y7B
#Medsky #Rheumsky
🍃March issue out now!
New data on cardiac events in #COPD, septic shock, climate change and #TB, and much more
🔗 www.thelancet.com/issue/S2213-...
NEW VIEWPOINT—Paediatric rheumatology care in #Europe: setting children and adolescents into focus bit.ly/4cp7usm #Medsky #Rheumsky
Attending the World Congress on #SystemicSclerosis in Athens next week?
Anna Clark, Editor-in-Chief, invites you to reach out with enquiries.
Explore our scope, reach & impact, commitment to publishing excellence, & more: hubs.li/Q03BLchR0
Attending the #EuropeanLupusMeeting in Lisbon next week?
Aisling O'Brien, Acting Deputy Editor, invites you to reach out with enquiries.
Explore our scope, reach & impact, commitment to publishing excellence, & more: hubs.li/Q03BLchR0
🆕“The identification of distinct and non-guideline-concordant pathways highlights persistent gaps in primary care management of patients with osteoarthritis. These findings underscore the need for targeted primary care interventions to support... care before knee replacement.”
...
Our March 2026 issue is live!
Including research in individuals at risk of developing arthritis, real-world data on anifrolumab in #SLE, #cardiovascular risk in #APS, and childhood-onset Sjögren's disease, plus much more! thelancet.com/journals/lan... #Rheumsky
Cover by @emma-cheng.bsky.social
NEW RESEARCH—Recombinant herpes zoster vaccine in patients with autoimmune rheumatic diseases in Brazil: a double-blind, randomised, placebo-controlled, phase 4, non-inferiority study bit.ly/4bZ4dQe @uspoficial.bsky.social
Plus linked Comment bit.ly/3MzdOD4
#Medsky #Rheumsky
NEW podcast episode🎧
Acting Deputy Editor, Aisling O'Brien, talks to Fiona Pearce & Rachel Tattersall about #HLH mortality rates in Europe
Listen now
Apple: bit.ly/3Off8LR
Spotify: bit.ly/3OFqGYM
Full Article: bit.ly/4p5f9hT
#Medsky #Rheumsky
Announcing The Lancet Medical Imaging & Theranostics. A new open access journal dedicated to clinical and technological advances in radiology, neuclear medicine, and theranostics. Artwork: Abstract medical image of a torso with vibrant organic shapes and geometric patterns, suggesting medical imaging. Credit: Shonagh Rae
🚀 Just launched – our new #goldopenaccess journal on medical imaging and theranostics!
Learn more about the journal’s mission and explore related content from The Lancet Group today: hubs.li/Q041CgFF0
#medsky
NEW RESEARCH—Patient profiles and early response in patients with systemic #lupus erythematosus initiating #anifrolumab: interim analysis from the ongoing multicentre observational REVEAL study bit.ly/4aj9YWz
Plus, linked Comment bit.ly/3ZliHT6
#Medsky #Rheumsky #SLE
Since their introduction 20 years ago, GLP-1 receptor agonists have revolutionised the treatment of diabetes and obesity. In our Feb editorial we discuss the current data on GLP-1 receptor agonists in rheumatic disease bit.ly/4c4N5Zi
#Medsky #Rheumsky
NEW REVIEW—The path to interception in psoriatic disease: from conceptual clarity to clinical translation
bit.ly/3ZD1NPE #Medsky #Rheumsky
Our Feb 2026 issue is live!
Including total versus partial knee replacement, vagus nerve stimulation in hand #OA, mortality due to #HLH, #pregnancy outcomes in #vasculitis, plus much more! thelancet.com/journals/lan... #Medsky #Rheumsky
Cover art by @emma-cheng.bsky.social
NEW RESEARCH—Long-term outcomes of abatacept in individuals at risk of developing rheumatoid arthritis (ALTO): a randomised, double-blind, placebo-controlled trial bit.ly/4pSERqq
Plus, linked Comment bit.ly/49v27Ga #Medsky #Rheumsky
NEW RESEARCH—Transcutaneous auricular vagus nerve stimulation versus sham stimulation in patients with erosive hand osteoarthritis (ESTIVAL): a randomised, multicentre, double-blind, sham-controlled trial bit.ly/4pKm4xD #Medsky #Rheumsky
NEW podcast episode🎧
Deputy Editor, Sophie Woolven, talks to John Isaacs & Josh Bennett about #sarcopenia and the RAMUS study, which looked at the skeletal muscle effects tofacitinib in #RA
Apple: bit.ly/49fUy6d
Spotify: bit.ly/3YSXxeC
Full Article: bit.ly/45tQXPn
#Medsky #Rheumsky
Workers demolish the facade of the East Wing of the White House on October 20, 2025 in Washington, DC. Copyright: Kevin Dietsch/Getty Images.
"the most disastrous year for US public health policy"
The US faces a critical public health crossroads as recent policy shifts threaten decades of progress.
What are the implications for future health security and scientific integrity?
Our Editorial: spkl.io/63326AcVQy
